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ABSTRACT 
Associative Tolerance to Nicotine’s Analgesic Effects: Studies on Number of 
Conditioning Trials and Corticosterone. (August 2003) 
Kristina Davis, B.S., Stephen F. Austin State University 
Chair of Advisory Committee: Dr. Antonio Cepeda-Benito 
 
 
This study examined the number of conditioning trials necessary to 
produce associative nicotine tolerance and the changes in corticosterone levels 
during the procedures.  Six independent groups of rats (N = 355) were run 
through tolerance acquisition procedures for 1, 5, or 10 conditioning sessions.  
Treatment groups were comprised of animals that received nicotine-environment 
pairings, animals that received nicotine explicitly unpaired with the drug 
administration environment, and control groups that received either saline 
throughout or no treatment.  Three of the groups were tested for nicotine-induced 
analgesia using the tail-flick and hot-plate assays, and three groups were blood 
sampled after either nicotine or saline injection.  Pairing of environment with 
nicotine produced greater tolerance for rats after 5 conditioning sessions in the 
tail flick and after 10 conditioning sessions in the hot-plate.  Corticosterone levels 
were elevated in all rats given nicotine.  Rats that received the nicotine-
environment pairing showed a conditioned release of corticosterone in response 
to the environment after both 5 and 10 conditioning sessions. 
  iv 
TABLE OF CONTENTS 
          Page 
 
ABSTRACT……..……………………………………………………….. iii 
TABLE OF CONTENTS………………………………………………… iv 
LIST OF FIGURES……………………………………………………...  v 
INTRODUCTION………………………………………………………...  1 
 Hypotheses………………………………………………   7 
METHOD………………………………………………………………….  9 
 Subjects……………………………………………………  9 
 Drugs………………………………………………………  9 
 Pre-Habituation Phase…………………………………..  9 
 Tail-Flick Analgesia Assessment……………………….  9 
 Hot-Plate Analgesia Assessment………………………. 10 
 Blood Sampling Procedures…………………………….. 11 
 Tolerance Development and Testing………………….. 11 
 
RESULTS………………………………………………………………... 14 
 Analgesia Assessments……………………………….. 14 
 CORT Assays…………………………………………… 22 
 
SUMMARY AND CONCLUSIONS……………………………………. 25 
REFERENCES………………………………………………………….. 35 
VITA…………………………………………………………………….... 40 
  v 
LIST OF FIGURES 
FIGURE         Page 
      1 Tail-flick results……………………………….…………………..      17 
      2 Hot-plate results.….….……………………….…………………..     20 
      3 CORT levels for saline controls.…………….…………………..     22 
      4 CORT levels for HC and DC rats..………….………....…….…..    24 
      5 Model for physiological pathways implicated in analgesia. ….     30 
  1 
INTRODUCTION 
Drug tolerance (defined as a decrease in a drug’s dose effects over 
continued exposure) is implicated as a key step in drug dependence and 
addiction (Ramsay and Woods, 1997).  Research to elucidate the mechanisms, 
both physiological and psychological, that control tolerance may, by extension, 
further the understanding of drug addiction.   
 Use of tobacco products is widespread, and addiction to nicotine found in 
tobacco products is well documented. Even in light of serious health risks 
associated with tobacco use and the fact that most smokers want to quit, 
becoming a nonsmoker is very difficult. Although smokers become chemically 
dependent on nicotine, the psychological dependence or reliance on smoking 
appears to play an important role in smoking and smoking relapse (Cepeda-
Benito, 1993). Tolerance may be a key component of nicotine addiction, and 
associative or conditioned tolerance may play a large in role in human nicotine 
use.  The psychological component of nicotine tolerance seems to be largely due 
to environmental stimuli that become associated with administration of the drug 
(Caggiula et al. 1989; Cepeda-Benito et al. 2000; Epstein et al. 1989).  
Therefore, an important step in understanding the nature of the psychological 
addiction to nicotine is to first understand the ways in which tolerance may be 
mediated by environmental cues. 
 
This thesis follows the style of Psychopharmacology. 
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 Previous work, which explored associative tolerance using morphine, 
investigated the analgesic effects of this drug (Cepeda-Benito and Tiffany 1992; 
1996a; 1996b).  Nicotine also produces analgesia, therefore, looking at nicotine 
analgesia, which is an easily measurable effect, enables the investigation of 
associative tolerance to nicotine.  Tolerance to nicotine’s analgesic effects is 
greater in animals that receive nicotine explicitly paired with a specific 
environment than in animals that receive the same amount of nicotine and 
exposure to the environment but with the environment and the nicotine explicitly 
unpaired (e.g., Cepeda-Benito et al. 1998). This contextual effect has been 
observed also in the development of tolerance to other effects of nicotine, such 
as nicotine's anorectic effects and nicotine-induced corticosterone (CORT) 
release (Caggiula et al. 1991). It has been proposed that this associative 
tolerance occurs through classical conditioning that involves pairing drug 
administration cues with drug effects, so that physiological mechanisms react "in 
expectancy" of a drug dose when presented with drug administration cues.  
 Caggiula and others (1993) compared CORT levels in rats that had 
received nicotine explicitly paired with a distinctive context with the CORT levels 
of nicotine-naïve rats never exposed to the distinctive context. These authors 
took blood samples for CORT assays after exposing both groups to saline 
injections in the distinctive context. CORT levels were higher in nicotine/context-
experienced rats than in nicotine treated rats that were exposed to the distinctive 
context for the first time on test day. Thus, these authors suggest that the 
distinctive context functioned as a conditioned stimulus (CS) that elicited a CORT 
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release or conditioned response (CR) that mimicked the unconditioned response 
(UR) or nicotine-induced CORT release.  
 However, Caggiula and colleagues (1991) reported that rats that received 
repeated nicotine injections in a distinctive environment developed conditioned 
tolerance to the CORT elevating effects of nicotine. That is, administration of 
nicotine in a predictive environment resulted in lower CORT release than 
administration of nicotine in a novel environment. These results could not be 
explained as stress-induced CORT release by the novel environment because 
injecting rats with either saline or nicotine in a novel environment did not elevate 
CORT levels with respect to corresponding controls that were injected in a 
familiar environment. Thus, Caggiula and colleagues interpreted their findings as 
evidence that the distinctive context environment was a conditioned stimulus that 
supported a reduction in CORT release, or that the conditioned response was 
opposite in direction to the unconditioned response of nicotine induced CORT 
release.  Thus, the findings by Caggiula and colleagues (1991) and the findings 
by Caggiula and colleagues (1993) appear to contradict each other and warrant 
further examination of the role of classical conditioning in supporting conditioned-
induction and conditioned-suppression of CORT release by an environment 
associated with repeated administration of nicotine. 
 Nonetheless, the idea that endocrine responses, especially CORT 
release, are implicated as mechanisms that affect the physiological reactions 
(and subsequently behavioral responses) to nicotine is a sound one.  With acute 
doses of nicotine in rats, CORT levels have been shown to rise and stay elevated 
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for at least some time after injection.  Cam and Bassett (1983) found significant 
increases in CORT starting at 5 min post-injection, and these elevated levels 
were sustained for 45 min post-injection, with a peak at 20 min post-injection.  
The initial increase in CORT over the first five minutes post-injection has been 
shown to follow the increasing plasma nicotine levels over this same time period, 
however, nicotine plasma levels begin to decline, while CORT levels stay 
elevated for at least 30 min post-injection (Cam et al. 1979) and up to 1 hour 
(Weidenfeld 1989; Mellon and Bayer, 1999).  In addition, Pauly, Grun, and 
Collins (1992) purport that elevations of CORT and decrements to nicotine 
sensitivity do not follow a simple linear relationship. 
Chronic nicotine administrations can produce a decrease in the CORT-
elevating response to nicotine (tolerance to the CORT-elevating effects).  Pauly 
and others (1992) found that mice given three daily nicotine injections over a 12 
day period showed sustained elevated CORT levels.  An acute nicotine 
challenge produced only small increases in CORT while saline treated animals 
given the same acute challenge showed larger CORT increases.  The time 
course for reduced response in CORT to repeated nicotine exposure has been 
studied, however, different types of exposure were necessary in each study to 
see this decrease.  Cam and Bassett (1984) found that CORT returned to 
baseline levels after 30 days of nicotine administration, whereas CORT levels 
returned to baseline levels as of the 5th treatment day in a study by Benwell and 
Balfour (1979).  These findings indicate that there is a development of tolerance 
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to the CORT elevating effects of nicotine (nicotine administration no longer 
produces CORT increases of the same magnitude as the initial exposure). 
 The most compelling evidence for the role of CORT in the development of 
nicotine tolerance can be found in adrenalectomy (ADX) studies. That is, ADX 
has been shown to increase sensitivity to nicotine's effects on physiological 
(heart rate, body temperature, acoustic startle) and behavioral (locomotion, 
rearing) systems (Pauly et al. 1988). Moreover, these authors showed that CORT 
replacement reversed the ADX influence on nicotine’s effects, and CORT 
administrations to intact animals produced subsensitivity to nicotine. Grun, Pauly, 
and Collins (1992) reported that while chronically nicotine-injected animals 
became tolerant to the effects of nicotine, tolerance to nicotine was not detected 
in animals that had been adrenalectomized. Grun, Pauly, Collins. (1992) also 
found that plasma CORT levels were significantly more elevated in mice 
repeatedly injected with nicotine than in mice injected with saline. Moreover, 
Johnson and colleagues (1995) found that ADX prevented sensitization to the 
locomotor increasing effects of nicotine, and chronic CORT replacement 
reinstated the nicotine sensitization effects commonly seen in intact animals. 
 Thus, researchers have proposed that conditioned activation of the HPA 
system and conditioned release of corticosterone may mediate the development 
of associative nicotine tolerance (Pauly et al. 1992; Caggiula et al. 1993; 1995). 
While circulating levels of corticosterone have been found to correlate with 
magnitude of nicotine tolerance, environmental cues associated with nicotine 
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delivery may elicit a conditioned corticosterone response (Pauly et al. 1992; 
Buske-Kirschbaum et al. 1996). 
The role of CORT in nicotine tolerance is not clear, particularly with 
regards to cue-dependent tolerance development.  For example, saline injections 
and handling procedures alone can elevate circulating CORT (Pauly et al. 1992).  
Peck, Disalver, and McGee (1991) demonstrated a reduction in nicotine 
sensitivity following a period of chronic stress.  Therefore, CORT changes appear 
to be differential depending on the experimental parameters of the drug 
administration. Additionally, classical conditioning paradigms not involving drug 
administration have also been shown to influence endocrine function, and this 
association with endocrine systems is implicated as important for the learning 
process.  More specifically, a conditioned CORT release has been shown in 
classical CS-US pairings after learning has occurred (Tomie et al. 2002), and, in 
a taste-aversion paradigm, a conditioned CORT release was seen in animals that 
received this conditioning (Ader 1976).  In addition, a peppermint odor associated 
with the administration of nicotine was shown to increase CORT levels when the 
odor was presented alone (Buske-Kirschbaum et al. 1996).  This indicates that 
drug effects can act as part of the CS-US pairings in classical conditioning, and 
that, even without drug responses, CORT levels can increase in response to 
situations that produce conditioned responses.   
The influences of stress, handling, prolonged exposure to nicotine, and 
conditioning mechanisms may all lead to changes in CORT levels. The 
relationship between CORT and associative nicotine tolerance is difficult to 
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discern given the wide array of influences on the physiological systems 
governing this tolerance. 
Hypotheses 
 The present research explored the effects of a number of conditioning 
sessions on the development of associative tolerance to the analgesic effects of 
nicotine and concurrent CORT level changes. First, the design tested for 
tolerance to nicotine-induced analgesia after 1, 5, and 10 conditioning sessions. 
Tolerance was expected to be greater in rats that received repeated 
administrations of nicotine explicitly paired with a distinctive test-context (DC 
rats) than in rats that received nicotine explicitly unpaired with the test-context 
(HC rats). The design also included a baseline control group that received equal 
exposure to the distinctive context but was injected with nicotine for the first time 
on testing day (SC rats).  
 In the second phase of the study, independent groups of DC, HC, and SC 
rats were also exposed to 1, 5, or 10 conditioning sessions, however, blood 
samples were taken in lieu of analgesia testing so that CORT levels after either 
nicotine or saline injection could be examined. It was hypothesized that DC rats 
would not develop tolerance to the CORT elevating effects of nicotine, but show 
a contextual release of CORT when injected with saline in the distinctive (drug-
paired) context. That is, if the presence of CORT is needed for the development 
of tolerance to nicotine's analgesic effects (e.g. Caggiula et al. 1993) and 
reverses hypersensitivity to nicotine produced by ADX (Pauly et al. 1988), it 
seems unlikely that DC rats would concurrently develop conditioned tolerance to 
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nicotine's CORT elevating effects and conditioned excitation of CORT release. 
Thus, it was expected that CORT levels after nicotine administration would not 
be lower for DC rats than HC rats. That is, injecting animals with saline in the 
distinctive context would produce a CORT elevation in DC rats with respect to 
HC rats.  Likewise, if chronic nicotine injections elevate circulating CORT levels, 
then greater CORT levels should be seen in HC vs. SC rats.    
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METHOD 
Subjects 
 The subjects were 355 experimentally naïve, male, Sprague Dawley from 
Harlan (Houston, TX) rats (approximately 75 days old on test day). They were 
housed individually in plastic cages with a bed of wood shavings.  A total of 216 
and 139 rats were used for analgesia and CORT assays, respectively. 
Drugs 
 Nicotine bitartrate was dissolved in physiological saline to produce a 
nicotine concentration of 1.0 mg/kg. This dose was used for all nicotine injections 
in all experiments.  All nicotine and vehicle solutions were subcutaneously 
injected in the scruff of the neck (1.0 ml/kg of body weight). 
Pre-Habituation Phase 
 After a week of acclimation to their colony room, the rats were weighed 
once daily for 3 days, weighed twice daily for an additional 3 days, and then 
weighed and injected with saline once daily for 8 days. All of these procedures 
took place in the colony room and were intended to reduce the discriminative 
salience and stress-inducing effects of injections and other handling procedures 
(see Cepeda-Benito and Tiffany 1996a). 
Tail-Flick Analgesia Assessment (N = 108) 
 The tail-flick apparatus (IITC, Model 33B) measures the latency for the rat 
to remove its tail away from a hot beam of light (e.g., Cepeda-Benito and Tiffany 
1992). The rat was restrained in an opaque cylinder (6.8 x 22 cm) that had a 
Plexiglas base (5.5 x 22 cm). Ventilation holes were made on top of and in the 
  10 
front of the tube. The rat's tail protruded from the back of the tube and was 
placed in a grooved plate such that the tail was directly under the light source. 
When the rat moved its tail away from the light-beam, a photo-sensitive cell 
tripped a timer and the tail-flick latency was automatically recorded. To avoid 
interactions between tail area stimulated and degree of analgesia (Yoburn et al. 
1984), each assessment was the mean of three consecutive trials with the 
location of the beam varied among the proximal, middle, and distal third of the 
rat's tail. The beam intensity was adjusted such that undrugged animals flicked 
their tails at about 4 s. A 15 s limit was used to prevent damage to the tail. The 
tester was blind to the rat’s treatment condition. 
Hot-Plate Analgesia Assessment (N = 108) 
 The hot-plate method measured a rat's latency to lick a paw or jump (e.g., 
Cepeda-Benito and Tiffany 1996b; Krank 1987). Rats were confined to the hot-
plate's surface in a chamber (30 X 30 X 30 cm) with a clear Plexiglas lid. The hot-
plate consisted of a metal surface, thermostatically controlled to a constant 
temperature of 52 C (ITC, Model 35D). Two observers, blind to the rat’s 
treatment condition, timed to the nearest hundredth of a second each rat's 
latency to the either lick a paw or jump, whichever came first (e.g., Krank 1987). 
The response latency was the mean of the two observations. The median 
difference between observers was 1.25 s. Rats were removed from the hot plate 
as soon as both observers detected either a lick or a jump. Although the 
observers were aware of each other’s timing, they were trained not to stop their 
watches unless they observed for themselves the rats response. Animals that 
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neither licked a paw nor jumped after 60 s were removed from the apparatus to 
prevent tissue damage. 
Blood Sampling Procedures (N = 139) 
 The blood was collected using the tail snip method: the tail was massaged 
for 6 to 8 sec and then a small portion of the tail (about 1 mm) was clipped off 
with a razor blade. Approximately 0.5 ml of blood was collected from the tail and 
centrifuged.  Plasma samples were then frozen at –70 oC until assay.  
Corticosterone assay was performed using a COAT-A-COUNT solid-phase 125I 
radioimmunoassay that showed linearity from 4.83 ng/ml (least detectable dose) 
to 1722.80 ng/ml with an average %CV of 4.42.  
Tolerance Development and Testing 
Following pre-habituation, each rat was given injections paired with a 
distinctive context and injections in its home cage environment. The interval 
between context exposures was 72 hrs and home cage injections were 
administered 24 and 48 hrs after each distinctive context exposure. For 
distinctive context exposures, each rat was weighed, individually carried in a 
small, plastic, bedding-lined container to the distinctive context room, injected 
with saline or a 1.00 mg/kg nicotine dose, put inside a tube, placed in a dark, 
scented cabinet, and mock-tested in either the tail-flick or the hot-plate device 4, 
8, and 13 min after the injection.  The distinctive-context room was set-up to be 
perceptually different from the colony area using visual, olfactory and auditory 
changes: the rooms light was dimmed (visual), apple-cinnamon air fresheners 
scented the holding cabinet (olfactory), and white noise was continuously played 
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(auditory). Each mock tail-flick test consisted of placing the rat on the tail-flick 
apparatus and going through the motions of conducting three tail-flick tests (i.e., 
without aiming the light beam at the tail). For each mock hot-plate test, the rat 
was removed from its tube and placed in a nonfunctional hot plate for 45 s.  After 
each mock test, the rat was returned to the scented cabinets. Rats were returned 
to their home cage environments 33 min after the last mock test. Rats not tested 
for analgesia but subjected to blood samplings on test day (CORT rats) were 
also exposed to tail-flick mock procedures. In addition, rats to be blood sampled 
had their tail massaged for a few seconds at 6 min after injection to mock blood 
collection procedures. For home cage injections, the rats were individually 
weighed, injected with either nicotine or saline, and returned to their home cage.  
Animals tested for nicotine's analgesic effects were divided randomly into 
four conditioning groups, which were further divided into tail-flick and hot-plate 
assays. DC rats received nicotine in the distinctive context and saline injections 
in the home cage environment. HC rats received saline in the distinctive context, 
nicotine for the first and saline for the second home cage injection that followed 
each context exposure. That is, HC rats received as much nicotine and context 
exposure as DC rats, but these two stimuli were explicitly unpaired. SC rats 
received as much exposure to the distinctive context and handling manipulations 
as DC and HC rats, however, SC animals did not receive nicotine until the test 
day. A fourth group of animals was never exposed to the experimental 
procedures until test day (Naïve rats). Animals subjected to blood sampling 
procedures were randomly divided into DC, HC, and SC groups. 
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Tail-flick and hot-plate test sessions occurred in the distinctive context 72 
hrs after the first, fifth, or tenth distinctive-context exposure. That is, independent 
groups of rats at each test session were injected with nicotine (1.00 mg/kg) and 
tested for analgesia in either the tail-flick or the hot plate in lieu of mock trials, at 
4, 8 and 13 min after the injection. The experimental design for analgesia 
assessments was a 4 (DC, HC, SC and Naïve groups) X 2 (tail-flick and hot-plate 
test devices) X 3 (1, 5, and 10 tolerance development sessions) design with 9 
animals per cell. 
Blood sampling procedures occurred between 6 and 7 min after the 
injection (or 2 min after the first mock tail-flick test) in the distinctive context 
during the first and 72 h after the fifth and tenth distinctive context exposures, in 
lieu of blood sampling mock trials.  For CORT assays, the design was a 2 (DC & 
HC groups) X 2 (test after saline or nicotine) X 2 (5 and 10 tolerance 
development sessions) design with 9 to 10 rats per cell. To examine the effects 
of handling and exposure procedures on CORT levels in nicotine naïve rats, six 
additional SC groups were tested with either nicotine or saline during the first, 
and after the fifth and tenth context exposure sessions.  
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RESULTS 
Analgesia Assessments 
 The data collected within each test device (tail flick or hot plate) at each of 
the three test sessions (after 1, 5, or 10 conditioning cycles) were analyzed using 
repeated measures Analysis of Variance (ANOVA). For each of the six data sets, 
the between factor was Group (DC, HC, SC and Naïve) and the within factor 
variable was Time (4, 8, and 13 min post injection). To protect the analyses 
against violations of the assumption of sphericity, adjusted, Huynh-Feldt degrees 
of freedom were used for significance testing of within factor and within by 
between factor effects.  
 In the presence of significant between group effects, a priori planned, 
repeated, pair-wise contrasts compared the mean response latencies of Naïve 
vs. SC rats, SC vs. HC rats, and HC vs. DC rats. It was predicted that SC and 
HC animals would display significantly greater response latencies than HC and 
DC animals, respectively. Lastly, significant Group by Time interaction effects 
were followed post hoc by comparing HC and DC rats within each assessment 
time (i.e., at 4, 8, and 13 min post injection). The p significance level for post hoc 
comparisons was adjusted using the Bonferroni method (.05 ÷ 3) to α = .016. 
Time and interaction effects were interpreted through visual inspection of 
latencies across testing and groups.  
 Tail-flick results. The analyses revealed significant and large Group effects 
at the tests conducted after the fifth, η2 = .542, F (3, 32) = 12.62, p < .001, and 
tenth, η2 = .755, F (3, 32) = 32.93, p < .001, sessions. Planned contrasts for 
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significant group effects indicated that DC rats responded with lower latencies 
than HC animals after both five, p = .011, and ten, p = .0001, sessions. However, 
HC rats were significantly faster than SC rats after five, p = .047, but not after 
ten, p = .84, sessions. Saline and Naïve animals did not differ from each other at 
any of the test sessions, all p’s > .39 (see Table 1).   
 
 
Table 1 Confidence intervals for analgesia tests.  Tail-flick and Hot-plate 
measures for animals tested after 1, 5 for 10 conditioning sessions (1 mg/kg 
nicotine) 
 
* Significant contrasts at p < .05 
 
 
 
 
There were significant Time effects at each of the three test sessions, with 
a medium effect size obtained for the test following the first session, η2 = .105, F 
(2, 59) = 3.77, p < .05, and large effect sizes after the fifth, η2 = .355, F (2, 57) = 
17.59, p < .001, and tenth, η2 = .332, F (2, 63) = 15.92, p < .001, sessions. 
Similarly, there were two significant Time by Group interaction effects after the 
fifth, η2 = .305, F (5, 57) = 4.68, p < .001, and tenth, η2 = .517, F (6, 63) = 11.40, 
p < .001, sessions. Visual inspection of Figure 1 suggests that latencies 
 Tail-Flick Contrasts (95% CI) Hot-Plate Contrasts (95% CI) 
Session DC – HC HC – SC DC – HC HC – SC 
First (-)1.98 – 1.21 (-)2.07 – 1.12 (-).24 – 12.67 (-)11.24 – 1.67 
Fifth (-)4.25 – (-).60 * (-)3.68 –          
(-).0028* 
(-)13.65 – 5.52 (-)10.43 – 8.74 
Tenth (-)4.71 –           
(-)2.83 * 
(-)1.04 - .849 (-)20.11 - .20 (-)22.36 –        
(-)2.04*  
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decreased as the time interval between injection and test increased. This effect 
seems to be largely due to the responses recorded for the DC animals, with the 
latencies for all other groups remaining largely unchanged throughout the testing 
times. Post hoc contrasts for the sixth session test revealed that DC rats had 
faster tail-flick latencies than HC rats at 8 min, p = .002, but not at 4 min, p = 
.018, or at 13 min, p = .530, after injection. However, contrasts for the eleventh 
session test revealed that DC rats had faster tail-flick latencies than HC rats at 4 
min, p = .010, 8 min, p < .000, and 13 min, p < .000, post injection (see Figure 1).   
Overall, the tail-flick results confirmed that pairing nicotine administrations 
with a distinctive context facilitated the expression of nicotine tolerance in that 
context. In fact, HC animals were relatively more tolerant to nicotine’s analgesic 
effects than SC animals only in one of the three conditions tested, i.e., after five 
conditioning sessions. The results also show that as few as five conditioning 
trials are needed for the expression of contextual tolerance to the analgesic 
effects of nicotine in the tail-flick. However, it appears that the most clear 
contextual effects occurred after the tenth session, where DC rats were faster 
than HC rats at each of the three testing times. Regarding time-dose effects, the 
most reliable interval to test for context tolerance effects was 8 min after 
injection, as this testing time yielded statistically significant effects both after five 
and ten conditioning sessions. Visual inspection of Figure 1 indicates that 
significant Time by Group interaction effects are due to more rapid declines in 
nicotine’s effects for the DC than the other groups. 
  17 
a) 
6
8
10
12
14
16
Naïve SC HC DC
Treatment Group
Fl
ic
k 
La
te
nc
y 
(s
ec
) 4min
8min
13min
  
b) 
6
8
10
12
14
16
Naïve SC HC DC
Treatment Group
Fl
ic
k 
La
te
nc
y 
(s
ec
) 4min
8min
13min
 
c) 
6
8
10
12
14
16
Naïve SC HC DC
Treatment Group
Fl
ic
k 
La
te
nc
y 
(s
ec
) 4min
8min
13min
 
Figure 1  Tail-flick results. Tail-flick latencies for animals tested with 1.00 mg/kg 
s.c. nicotine at the 4, 8, and 13 min post-injection test times  a) after 1 
conditioning session, b) after 5 conditioning sessions, and c) after 10 conditioning 
sessions. During conditioning, DC rats received nicotine explicitly paired with a 
drug administration environment.  HC rats received equivalent amounts of 
nicotine and context exposure but with the two explicitly unpaired.  SC rats 
received saline during their exposures to the distinctive context, and Naïve rats 
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received no treatment until test day. 
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 Hot plate results. Unlike the tail-flick results, the analyses only revealed a 
significant Group effect at the test conducted after the tenth, η2 = .048, F (3, 32) 
= 11.08, p < .0001, session. Planned contrasts for this significant group effect 
indicated that DC rats responded with marginally lower latencies than HC 
animals, p = .054, and HC rats were significantly faster than SC rats, p = .020. 
Like in the tail-flick assay, Saline and Naïve animals did not differ from each 
other.  (See Table 1)   
There were significant, large Time effect sizes after the fifth, η2 = .245, F 
(2, 57) = 10.39, p < .001, and tenth, η2 = .522, F (2, 49) = 34.94, p < .001, 
sessions. However, there was only one significant Time by Group interaction 
effect, which was obtained after the tenth session, η2 = .459, F (5, 49) = 9.06, p < 
.001. Visual inspection of Figure 2 suggests that latencies decreased as the time 
interval between injection and test increased, particularly for DC and HC animals. 
A Post hoc contrast for the eleventh session test revealed that DC rats had faster 
paw-lick latencies than HC rats at 8 min, p = .008, but not at 4 min, p = .846, or at 
13 min, p = .049, post injection.  
Overall, the hot-plate results were not as robust as the tail-flick results. 
Although, pairing nicotine administrations with a distinctive context facilitated the 
expression of nicotine tolerance in that context, this effect was clearly observed 
only at the 8 min post injection test after the tenth session. The results indicate 
that at least ten conditioning trials are needed for the expression of contextual 
tolerance to the analgesic effects of nicotine in the hot-plate. This is somewhat 
congruent with the results obtained with the tail-flick assay, as the most clear 
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contextual effects in the tail flick also occurred after the tenth session. Moreover, 
similar to the tail-flick assay, the most reliable interval to test for context tolerance 
effects in the hot plate was 8 min post injection. Visual inspection of Figure 2 
indicates that the significant Time by Group interaction effect at the ten session 
test was due to faster, nicotine effect declines in DC and HC rats than in SC and 
Naïve rats. 
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Figure 2  Hot-plate results. Hot-plate latencies to lick or jump at the 4, 8, and 13 
min tests (1.00 mg/kg s.c. nicotine) a) after 1, b) after 5, and c) after 10 
conditioning sessions.  During conditioning, DC rats received nicotine explicitly 
paired with a drug administration environment.  HC rats received equivalent 
amounts of nicotine and context exposure but with the two explicitly unpaired.  
SC rats received saline during their exposures to the distinctive context, and 
Naïve rats received no treatment until test day.
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CORT Assays 
 SC animals. A two-way ANOVA examined the effects of context exposure 
on CORT levels, with Test Treatment (Nicotine vs. Saline) and Context Exposure 
(1st vs. 5th vs. 10th) as the two between group factors. The between subjects 
comparisons yielded significant main effects for both Factors and for the 
Interaction term. The impact of nicotine on CORT levels was clear as levels of 
CORT were significantly higher after nicotine than after saline injections, η2 = 
.507, F (1, 54) = 55.5, p < .0001. There also was a significant Context Exposure 
effect, η2 = .145, F (2, 54) = 4.59, p < .05, and a Test by Context interaction, η2 = 
.113, F (2, 54) = 3.43, p < .05.  Repeated contrasts between CORT levels at 
sessions 1 vs. 5, and 5 vs. 10 were analyzed separately for saline and nicotine 
rats. The results indicated that, in congruence with the Context Exposure main 
effect, SC rats tested with saline showed an overall decrease in CORT from 
session 1 to session 5, p = .005, and a CORT increase from session 5 to session 
10, p = .04. Conversely, SC rats tested with nicotine showed no CORT changes 
from session 1 to session 5, p = .83, and a marginal increase from session 5 to 
session 10, p = .057. (See Figure 3)  
 Overall, the CORT assays conducted on the blood samples collected from 
SC animals indicated that novelty (or stress) effects increase CORT levels in 
rats, as observed by a significant decline of CORT levels between session 1 and 
session 5 in saline tested rats. However, the results also suggested that with 
prolonged exposure to the experimental procedures CORT levels increased from 
session 5 to session 10. Likewise, nicotine CORT elevating effects also tended to 
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increase with level of context exposure from session 5 to session 10 but this 
effect was only marginally significant. 
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Figure 3  CORT levels for saline controls.  Represented here are the CORT 
levels for SC (saline control) animals tested with saline compared to animals 
tested with nicotine during the first, after 5 conditioning sessions, and after 10 
conditioning sessions. 
 
 
HC and DC animals. A three-way ANOVA examined the effects of context 
exposure on CORT levels, with Test Treatment (Nicotine vs. Saline), Context 
Exposure (5th vs. 10th), and Group (DC vs. HC) as the three between group 
factors (these results are depicted in Figure 4). The between subjects 
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comparisons yielded significant main effects for all factors but not for any of the 
Interaction terms. Levels of CORT were significantly higher after nicotine than 
after saline injections, η2 = .276, F (1, 71) = 27.01, p < .0001, after the 10th than 
after the 5th context exposure, η2 = .140, F (1, 71) = 11.51, p < .005, and in DC 
than in HC rats, η2 = .159, F (1, 71) = 13.4, p < .001. 
 The CORT elevating effects of nicotine were evident in nicotine 
experienced animals, or HC and DC rats. That is, CORT levels were higher after 
nicotine than saline. Tolerance development to nicotine's effects on CORT was 
not observed, that is CORT levels increased from session 5 to session 10 in 
nicotine experienced rats (see Figure 3). Moreover, under conditions conducive 
to the development of contextual tolerance to the analgesic effects of nicotine, 
DC rats tested with saline showed higher levels of CORT than HC rats (see 
Figure 4). These results suggest that pairing the context with nicotine resulted in 
associative learning with the context becoming a conditioned stimulus capable of 
eliciting a conditioned response or CORT elevation effect. 
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Figure 4  CORT levels for HC and DC rats.  DC rat (nicotine explicitly paired with 
distinctive context) and HC rat (nicotine explicitly unpaired with distinctive 
context) CORT levels for after 5 and 10 conditioning sessions for both the a) 
saline tested animals and b) nicotine tested animals. 
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SUMMARY AND CONCLUSIONS 
This investigation shows that associative tolerance to nicotine analgesia 
as measured by the tail-flick test can develop in as few as 5 conditioning 
sessions.  However, associative tolerance to nicotine’s analgesic effects was not 
observed for the hot-plate assay until after ten conditioning sessions and only at 
the 8 min post-injection test.  This difference between the tail-flick and hot-plate 
tests may be due to differential effects of nicotine on spinally and supraspinally 
mediated nociceptive responding.  
Several authors have proposed that whereas the tail-flick response is 
primarily a spinally mediated response, the hot-plate test is both spinally and 
supraspinally mediated (e.g., Yang et al. 1992). Yang and colleagues found that, 
with chronic nicotine exposure (extended elevations of nicotine levels in plasma) 
achieved through mini-pump infusion, tolerance to the analgesic effects of 
nicotine was only seen for the hot-plate tests. This indicates that, when 
compared to the results of the current study, chronic nicotine administration gives 
rise to tolerance to the analgesic effects of nicotine that are mediated by 
supraspinal mechanisms. However, a drug regime consisting of repeated acute 
dosing appears more conducive to the development of associative tolerance to 
the analgesic effects of nicotine that are mediated via spinal mechanisms.   
Moreover, Caggiula and others (1995) found that both peripheral 
(chlorisondamine) and central (mecamylamine) antagonists interrupted nicotine-
induced antinociception as measured by the tail-withdrawal method, but only the 
central antagonist (mecamylamine) produced an interruption in hot-plate 
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responses to nicotine.  Rogers and Iwamoto (1993) showed that both spinal and 
brain cholinergic systems are responsible for the antinociceptive effects of 
nicotine and that antagonists to these systems differentially affect tail-flick and 
hot-plate responses. Their study found that antagonists of nicotinic receptors in 
the spinal cord do not appear to eradicate antinociceptive responses indicating 
that the lumbar spinal level uses other neurotransmitter systems to produce 
antinociception in response to nicotine.  However, they also showed that, through 
antagonism of supraspinal nicotinic receptors, central nicotinic receptors appear 
to exert effects on NE, 5-HT, and muscarinic receptors in the spinal cord.   
Therefore, it seems clear that tail-flick and hot-plate responses are not mediated 
by entirely the same mechanisms, and that manipulations in the present 
investigation may not have affected these different mechanisms in the same way. 
An additional reason why the context effects were clearer in the tail-flick is 
that the hot-plate assay seems to have a lower dose for optimal response than 
the tail-flick (Caggiula et al. 1995). That is, Caggiula and colleagues found a 
contextual effect to a 0.25 mg/kg, and a 0.50 mg/kg nicotine, test-dose, but not to 
a 0.75 mg/kg test dose. Therefore, it is possible that the 1.00 mg/kg dose 
produced changes in the spinal cholinergic system but did not affect the 
supraspinally mediated cholinergic system leading to the hot-plate/ tail-flick 
discrepancies. 
The present investigation contributes to a better understanding of how 
CORT release may mediate the development of associative tolerance to 
nicotine's analgesic effects, and is directly related to seemingly contradictory 
  28 
results in previous investigations. Caggiula and others (1993) demonstrated that 
following a saline challenge in the distinctive context, animals that had received 
five nicotine injections paired with the distinctive context at a 48 hr inter-dose-
interval (IDI) had higher levels of blood CORT than animals that had received the 
same drug regime but were exposed for the first time to the distinctive context on 
test day. That is, exposure to the context had been associated with nicotine-
induced CORT level increases. However, in an earlier investigation, Caggiula 
and colleagues (1991), found that nicotine-induced CORT release in rats that 
had received eleven nicotine injections (24 hr IDI) in a distinctive context were 
not higher in the distinctive context than in a novel environment but lower. Thus, 
together the Caggiula laboratory findings left it unclear whether context-induced 
CORT release or context-induced CORT suppression was responsible for the 
development of associative tolerance to nicotine.  
The data in the present investigation were consistent with the finding that 
CORT reduces sensitivity to nicotine effects.  It was also consistent with the 
hypothesis that conditioned corticosterone release may play a large role in the 
development and expression of associative tolerance to the analgesic effects of 
nicotine. That is, CORT levels were elevated in animals that received nicotine 
injections paired with the distinctive context (DC rats) than in animals that 
received as much nicotine and exposures to the context but with these stimuli 
explicitly unpaired (HC rats). Moreover, the contextual CORT release was 
observed when the conditioned stimulus (distinctive environment) was presented 
with and without the unconditioned stimulus (nicotine). In congruence with the 
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findings and hypothesis described above, DC animals were less sensitive to 
nicotine’s analgesic effects, while having increased CORT, than HC animals.  
The precise mechanisms that may be involved in endocrine pathways to 
reduce nicotine-induced analgesia in the present experiment are unclear.  It has 
been established that nicotine acts on cholinergic receptors in brain to release 
corticotropin-releasing factor (CRF) from the hypothalamus. CRF in turn 
stimulates the release of adrenocorticotropic hormone (ACTH) and B-endorphin 
(B-end) from the pituitary gland (see Feldman et al. 1997).  That is, 
hypophysectomy eradicates CORT release in response to nicotine while 
exogenous ACTH administration reinstates CORT releases in response to 
nicotine – indicating that it is the CRF-ACTH pathway that is necessary for 
nicotine to induce CORT increases (Cam et al. 1979).  Thus, nicotine shares, to 
some extent, the same pathway that controls stress-induced antinociception 
(Munck et al. 1984). Given that B-end can act on the central nervous system to 
reduce the afferent flow of pain information from the peripheral nervous system 
(see Feldman et al. 1997), it is possible that at least part of nicotine’s 
antinociceptive effects are exerted through the stimulation of B-end.  This 
hypothesis is congruent with previous findings showing that exposure to novel 
(stressful) stimuli disrupts the expression of associative tolerance to nicotine 
(e.g., Caggiula et al. 1993) 
The current studies showed a decrease in nicotine-induced analgesia after 
repeated exposures to nicotine paired with the environment, however, CORT 
levels remained high.  Conditioned release of CORT may explain this finding.  It 
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appears that CORT acts as a mediator of B-end by direct actions on the pituitary 
and by decreasing release of CRF through negative feedback systems (Munck et 
al. 1984).  In addition, CORT acts to downregulate Acetylcholine (ACh) receptors 
(Munck et al. 1984).   Therefore, it is possible that conditioned CORT release 
acts to decrease nicotine-induced analgesia by inhibiting the CRF-ACTH / B-end 
pathways and by downregulation of ACh receptors thereby decreasing nicotine’s 
stimulatory effects on these systems (see Figure 5). This conditioned pre-
injection release of CORT would lead to high circulating CORT levels but low 
analgesia in response to nicotine as was found in this investigation.    
Additionally, CORT inhibition of ACTH and B-end versus the 
downregulation of nicotinic receptors by CORT may be differentially affected by 
the parameters surrounding the acquisition of tolerance (i.e., one pathway may 
exert more influence in the learning aspects of tolerance while the other may 
influence the physiological aspects of tolerance).  Grun and colleagues (1992) 
and Pauly, Grun, and Collins (1990) found that tolerance in mice was achieved 
without any changes in nicotinic receptor number or affinity.  When looking at the 
experimental design of those studies, it seems possible that the procedure used 
by these authors may have allowed for conditioning to associative cues (although 
associative cues were not manipulated), therefore, their findings that nicotinic 
receptors remained unchanged while CORT levels were increased just prior to 
injection could indicate that associative tolerance is not mediated by nicotinic 
receptor changes.   
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Figure 5 Model for physiological pathways implicated in analgesia. This model 
shows possible pathways for analgesia induced by nicotine and stress/ learning/ 
conditioning as well as the potential convergence of these systems. 
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The above argument is further supported by Hulihan-Giblin and others 
(1990) who found, using procedures that would be conducive to measuring non-
associative tolerance (subcutaneous daily injections were given and testing 
occurred with intravenous injections), that changes in nicotinic receptor binding 
were highly correlated with tolerance to nicotine.   
Therefore, it may be postulated that physiological tolerance to nicotine 
may be mediated by long-term changes in nicotinic receptor activity, and CORT 
release in response to nicotine may not act efficiently to inhibit B-end thereby 
producing changes in nicotine responsiveness mostly at the receptor level.   
Further, CORT increases in response to associative cues precede nicotine 
administration, which may allow for more effective control of B-end thereby 
producing larger tolerance effects to the analgesic effects of nicotine (see Figure 
5). 
However, it must be pointed out that stress, conditioning, and nicotine 
appear to act on norepinephrine (NE), Serotonin (5-HT), and N-methyl-D-
aspartate (NMDA) receptor systems (Trujillo 2000; Furst 1999).  All of these 
systems may lead to analgesia through their respective physiological cascades.  
The implication of so many pathways to nicotine-induced antinociception makes 
our interpretation of results pertaining to the endocrine mechanisms associated 
with nicotine analgesia one of many other possibilities. Moreover, because 
nicotine and stress act on the same systems to produce analgesia, it is clear that 
the antinociceptive properties of nicotine are confounded with stress-elicited 
antinociception and is difficult to isolate or control in an associative learning 
  33 
paradigm.  In addition, if physiological responses to learning are factored into the 
converging pathways of stress and nicotine, the mechanisms involved in 
associative tolerance to nicotine’s analgesic effects are clearly very complex, and 
it will take extended research to define these pathways. 
The next step to elucidating the physiological mechanisms that converge 
in associative tolerance paradigms may be to explore the role of the other 
players in the physiological cascades associated with stress, conditioning, and 
nicotine (B-end, NE, NMDA, CRF, ACTH, and 5-HT).  Previous reports have 
shown that the CRF / ACTH pathway is necessary for nicotine-induced analgesia 
(Cam et al. 1979). The interruption of nicotine-induced analgesia may be due to a 
loss of B-end, because hypophysectomy eradicated CRF-stimulated pro-
opiomelanocortin (POMC) release, which is the common precursor to ACTH and 
B-end in intact animals (see Figure 5).  Therefore, if B-end is the key player in 
analgesia within associative tolerance paradigms, then inhibition of B-end should 
significantly decrease analgesia in response to nicotine.  Further, if B-end has a 
primary role then, all other systems being “equal”, associative tolerance should 
show a decrease in B-end activity while non-associative tolerance should show 
sustained elevations in B-end in response to nicotine. 
It will also be necessary to study NE, NMDA, and 5-HT systems 
separately in the pathways to the development of associative tolerance to 
nicotine's analgesic effects.  Moreover, all of the physiological systems 
mentioned seem to be convergent systems in that multiple factors may lead to 
activation of these systems.   Exactly how these systems converge and interact 
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is unclear, however, elucidating this interaction may be an important step to 
understanding nicotine addiction.  Although the actions of these compounds are 
known in certain stress-, learning-, or nicotine-induced pathways, associative 
tolerance provides a situation where stress-, learning-, and nicotine- induced 
pathways converge.  Therefore, the physiological importance that each of these 
compounds contributes to associative tolerance to nicotine is most likely modified 
by the converging psychological and physiological mechanisms apparent in 
associative tolerance paradigms.   Additionally, the present investigation only 
looked at endocrine responses during nicotine-induced analgesia.  The 
endocrine system likely plays a different role in some of nicotine’s other effects 
(e.g., B-end may not be the primary player in the pathways to the anorectic or 
locomotor effects of nicotine).   
If the convergent systems hypothesis (stress, learning, and nicotine) is 
correct, some degree of cross-tolerance would be expected.  Unpublished work 
in this lab has shown this to occur.  Animals conditioned to nicotine in the 
distinctive context (DC animals) showed higher levels of tolerance to morphine in 
that same context than did HC or SC animals.  This further supports the idea that 
a significant part of associative tolerance to nicotine is influenced by the 
conditioning mechanisms, and, as previously stated, the physiological 
components within these systems remains to be fully explained in the context of 
associative tolerance. 
Nicotine addiction in humans is very complex, and associative tolerance is 
just one aspect of continued nicotine use.  The implication that learning and 
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conditioning mechanisms are crucial to nicotine addiction is not new, however, a 
better understanding of the human condition may be obtained through a close 
look at the physiological mechanisms that drive learning and conditioning within 
the context of drug use.  It seems likely that the physiological mechanisms 
involved in nicotine addiction, especially in regards to conditioning, are likely to 
be involved in other forms of addiction as well. 
  36 
REFERENCES 
Ader R (1976) Conditioned adrenocortical steroid elevations in the rat.  J Comp 
Physiol Psychol 90:1156-1163 
Benwell ME, Balfour DJK (1979) Effects of nicotine administration and its 
withdrawal on plasma corticosterone and brain 5-hydroxyindoles. 
Psychopharmacology 63:7-11 
Buske-Kirschbaum A, Grota L, Kirschbaum C, Bienen T, Moynihan J, Ader R, 
Blair ML, Hellhammer DH, Felten DL (1996) Conditioned increase in 
peripheral blood mononuclear cell (PBMC) number and corticosterone 
secretion in the rat. Pharmacol Biochem Behav 55:27-32 
Caggiula AR, Epstein LH, Antelman SM, Saylor SS, Perkins KA, Knopf S, Stiller 
R (1991) Conditioned tolerance to the anorectic and corticosterone-
elevating effects of nicotine. Pharmacol Biochem Behav 40:53-59 
Caggiula AR, Epstein LH, Antelman SM, Saylor S, Knopf S, Perkins KA, Stiller R 
(1993) Acute stress or corticosterone administration reduces 
responsiveness to nicotine: Implications for mechanism of conditioned 
tolerance. Psychopharmacology 111:499-507 
Caggiula AR, Epstein LH, Perkins KA, Saylor S (1995) Different methods of 
assessing nicotine-induced antinociception may engage different neural 
mechanisms.  Psychopharmacology 122:301-306 
Caggiula AR, Epstein LH, Stiller R (1989) Changing environmental cues reduces 
tolerance to nicotine-induced anorexia. Psychopharmacology 99:389-392 
  37 
Cam GR, Bassett JR (1983) The effect of acute nicotine administration on 
plasma levels of the thyroid hormones and corticosterone in the rat.  
Pharmacol Biochem Behav 19:559-561 
Cam GR, Bassett JR (1984) Effect of prolonged exposure to nicotine and stress 
on the pituitary-adrenocortical response; the possibility of cross-
adaptation. Pharmacol Biochem Behav 20:221-226 
Cam GR, Bassett JR, Cairncross KD (1979) The action of nicotine on the 
pituitary-adrenal cortical axis.  Arch Int Pharmacodyn 237:49-66 
Cepeda-Benito A (1993) Meta-analytical review of the efficacy of nicotine 
chewing gum in smoking treatment programs. J Consult Clin Psychol 
61:822-830 
Cepeda-Benito A, Reynoso J, Erath S (2000) Dose-response analyses of 
associative tolerance to nicotine analgesia in the rat: Tail-flick and hot-
plate tests. Exp Clin Psychopharmacol 8:112-116 
Cepeda-Benito A, Reynoso J, McDaniel EH (1998) Associative tolerance to 
nicotine analgesia in the rat: tail-flick and hot-plate tests. Exp Clin 
Psychopharmacol 6:248-254 
Cepeda-Benito A, Tiffany ST (1992) Effect of number of conditioning trials on the 
development of associative tolerance to morphine.  Psychopharmacology 
109:172-176 
Cepeda-Benito A, Tiffany ST (1996a) Unsignaled morphine delivery does not 
disrupt the development of associative morphine tolerance in the rat.  
Pharmacol Biochem Behav 54:575-580 
  38 
Cepeda-Benito A, Tiffany ST (1996b) Test-specific manifestations of associative 
tolerance to the analgesic effects of morphine in the rat. Psychobiology 
24:327-332 
Epstein LH, Caggiula AR, Stiller R (1989) Environment-specific tolerance to 
nicotine. Psychopharmacology 97:235-237 
Feldman RS, Meyer JS, Quenzer LF eds (1997) Neuropsychopharmacology. 
Snaver Association Inc Press, Sundulan, MA 
Furst S (1999) Transmitters involved in antinociception in the spinal cord. Brain 
Res Bull 48:129-141 
Grun EA, Pauly JR, Collins AC (1992) Adrenalectomy reverses chronic injection-
induced tolerance to nicotine. Psychopharmacology 109:299.304 
Hulihan-Giblin BA, Lumpkin MD, Kellar KJ (1990) Effects of administration of 
nicotine on prolactin release in the rat: inactivation of prolactin response 
by repeated injections of nicotine.  J Pharmacol Exp Ther 252:21-25 
Johnson DH, Svensson AI, Engel JA, Soderpalm B (1995) Induction but not 
expression of behavioral sensitization to nicotine in the rat is dependent 
on glucocorticoids. Eur J Pharmacol 276:155-164 
Krank MD (1987) Conditioned hyperalgesia depends on the pain sensitivity 
measure.  Behav Neurosci 101:854-857 
Mellon RD, Bayer BM (1999) The effects of morphine, nicotine and epibatidine 
on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. 
J Pharmacol Exp Ther 288:635-642 
  39 
Munck A, Guyre PM, Holbrook NJ (1984) Physiological functions of 
glucocorticoids in stress and their relation to pharmacological actions. 
Endocr Rev 5:25-44 
Pauly JR, Grun EA, Collins AC (1990) Chronic corticosterone administrations 
modulate nicotine sensitivity and brain nicotine receptor binding in C3H 
mice. Psychopharmacology 101:310-316 
Pauly JR, Grun EA, Collins AC (1992) Tolerance to nicotine following chronic 
treatment by injections: a potential role for corticosterone. 
Psychopharmacology 108:33-39 
Pauly JR, Ullman EA, Collins AC (1988) Adrenocortical hormone regulation of 
nicotine sensitivity in mice. Physiol Behav 44:109-116 
Peck JR, Disalver SC, McGee M (1991) Chronic forced swim stress produces 
subsensitivity to nicotine. Pharmacol Biochem Behav 38:647-650 
Ramsay DS, Woods SC (1997) Biological consequences of drug administration: 
Implications for acute and chronic tolerance. Psychol Rev 104:170-193 
Rogers DT, Iwamoto ET (1993) Multiple spinal mediators in parenteral nicotine-
induced antinociception. J Pharmacol Exp Ther 267:341-349  
Tomie A, Silberman Y, Williams K, Phorecky LA (2002) Pavlovian autoshaping 
procedures increase plasma corticosterone levels in rats.  Pharmacol 
Biochem Behav 72:507-513 
Trujillo KA (2000) Are NMDA receptors involved in opiate-induced neural and 
behavioral plasticity? Psychopharmacology 151:121-141 
  40 
Weidenfeld J, Bodoff M, Saphier D, Brenner T (1989) Further studies on the 
stimulatory action of nicotine on adrenocortical function in the rat. 
Neuroendocrinology 50:132-138 
Yang C, Wu W, Zbuzek VK (1992) Antinociceptive effect of chronic nicotine and 
nociceptive effect of its withdrawal measured by hot-plate and tail-flick in 
rats. Psychopharmacology 106:417-420 
Yoburn BC, Morales R, Kelly DD, Inturrisi EC (1984) Constraints on the tail-flick 
assay: morphine analgesia and tolerance are dependent on locus of 
stimulation. Life Sciences 34:1755-1762 
  41 
VITA 
 
Kristina Davis 
P.O. Box 632406 
Nacogdoches, TX 75963 
 
Education 
B.S. Psychology (May 2001) 
Stephen F. Austin State University 
 
M.S. Psychology (August 2003) 
Texas A&M University 
  
